Solara Active Pharma Sciences Limited has informed the Exchange about press release dated 01-Nov-2022 titled Solara receives European Approval (CEP) to manufacture Ibuprofen from its flagship Vizag facility
Solara Active Pharma Sciences Limited has informed the Exchange about press release dated 01-Nov-2022 titled Solara receives European Approval (CEP) to manufacture Ibuprofen from its flagship Vizag facility